Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) — The “Fertility Testing Devices Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Global Fertility Testing Devices Market, valued at USD 690.46 Million in 2024, is projected to experience a CAGR of 7.77% to reach USD 1.06 billion by 2030.
Market expansion is driven by the increasing global prevalence of infertility and a societal trend towards delayed pregnancies, which necessitates reproductive health monitoring. Heightened awareness of fertility issues and continuous advancements in diagnostic technologies further propel demand.
The growing prevalence of infertility worldwide directly drives demand for diagnostic solutions as individuals and couples seek to understand and address their reproductive challenges. This widespread issue necessitates accurate and accessible testing to identify underlying causes and facilitate timely intervention. According to SingleCare, January 2025, ‘Infertility statistics 2025:
How many couples are affected by infertility? ‘, approximately 1 in 6 people globally have experienced infertility at some point in their lives. This substantial demographic indicates a consistent and expanding user base for various fertility testing devices, from ovulation prediction kits to more advanced diagnostic tools.
Key Market Challenges
The substantial cost of advanced fertility testing devices and associated procedures significantly impedes the growth of the Global Fertility Testing Devices Market by restricting access for a considerable segment of the population. When the financial burden of initial diagnostics and subsequent treatments is high, many individuals and couples are deterred from seeking necessary reproductive healthcare. This issue is particularly pronounced in regions lacking comprehensive insurance coverage or robust public funding for fertility services.
Key Market Trends
Advancements in at-home fertility testing technologies are significantly reshaping the market by offering individuals convenient and private diagnostic options outside traditional clinical settings. The increasing availability of user-friendly kits for hormone level assessment, ovulation prediction, and male fertility screening empowers consumers with greater control over their reproductive health journey. This trend reduces barriers to initial fertility assessment, encouraging proactive engagement with reproductive health monitoring, especially for those who value discretion.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $11.32 Billion |
| Forecasted Market Value (USD) by 2030 | $18.38 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
Report Scope:
Key Market Players Profiled:
- Church & Dwight Co., Inc.
- Fairhaven Health LLC
- Geratherm Medical AG
- Abbott Laboratories, Inc.
- Quidel Corporation
- Procter & Gamble
- Swiss Precision Diagnostics GmbH
- Clearblue
- HiLin Life Products Inc.
- Fertility Focus Limited.
By Product Type:
- Ovulation Prediction Kits
- Fertility Monitors
- Male Fertility Testing Product
By Application:
- Female Fertility Testing
- Male Fertility Testing
By End User:
- Hospitals
- Fertility Clinics
- Home Care Settings
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/9xucu6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Fertility Testing Devices Market
